IVF Key Statistics, Chart & Performance
The current stock price of IVF is 1.11 USD. In the past month the price increased by 31.75%.
IVF Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to IVF.
IVF Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to IVF. IVF may be in some trouble as it scores bad on both profitability and health.
IVF Financial Highlights
Over the last trailing twelve months IVF reported a non-GAAP Earnings per Share(EPS) of -644.61. The EPS decreased by -808.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -155.09% | ||
| ROE | -499.38% | ||
| Debt/Equity | 0.31 |
IVF Forecast & Estimates
5 analysts have analysed IVF and the average price target is 146.88 USD. This implies a price increase of 13132.43% is expected in the next year compared to the current price of 1.11.
For the next year, analysts expect an EPS growth of 92.84% and a revenue growth 10.02% for IVF
IVF Ownership
IVF Latest News, Press Relases and Analysis
IVF Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.55 | 193.136B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.44 | 174.712B | ||
| SYK | STRYKER CORP | 23.88 | 136.172B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.2 | 109.878B | ||
| BDX | BECTON DICKINSON AND CO | 10.9 | 59.193B | ||
| IDXX | IDEXX LABORATORIES INC | 43.64 | 51.087B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.92 | 44.567B | ||
| RMD | RESMED INC | 21.46 | 40.282B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.77 | 36.023B | ||
| DXCM | DEXCOM INC | 27 | 27.364B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IVF
Company Profile
INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Company Info
INVO FERTILITY INC
5582 Broadcast Court
Sarasota FLORIDA US
Employees: 28
Phone: 19788789505
INVO FERTILITY INC / IVF FAQ
What does INVO FERTILITY INC do?
INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
What is the stock price of INVO FERTILITY INC today?
The current stock price of IVF is 1.11 USD. The price increased by 0.45% in the last trading session.
Does INVO FERTILITY INC pay dividends?
IVF does not pay a dividend.
How is the ChartMill rating for INVO FERTILITY INC?
IVF has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists IVF stock?
IVF stock is listed on the Nasdaq exchange.
Is INVO FERTILITY INC (IVF) expected to grow?
The Revenue of INVO FERTILITY INC (IVF) is expected to grow by 10.02% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
When does INVO FERTILITY INC (IVF) report earnings?
INVO FERTILITY INC (IVF) will report earnings on 2026-04-28, after the market close.